Mealey's (May 16, 2023, 1:49 PM EDT) -- NEW ORLEANS — A Fifth Circuit U.S. Court of Appeals panel will hear arguments May 17 in an appeal by the Food and Drug Administration and a drug company challenging district court and circuit court rulings that would stay the FDA’s approval of the abortion drug mifepristone and subsequent changes by the agency to the drug’s dosage and prescribing requirements....